Yu X, Deng Q, Gao X, He L, Hu D, Yang L
Front Endocrinol (Lausanne). 2025; 16:1523785.
PMID: 40034225
PMC: 11872706.
DOI: 10.3389/fendo.2025.1523785.
Lenart N, Rao S
Cancer Metastasis Rev. 2024; 44(1):6.
PMID: 39585533
DOI: 10.1007/s10555-024-10223-5.
So K, Su Z, Cheung J, Choi S
Diagnostics (Basel). 2024; 14(19).
PMID: 39410576
PMC: 11475990.
DOI: 10.3390/diagnostics14192172.
Rodriguez-Tirado C, Sosa M
Clin Exp Metastasis. 2024; 41(4):275-299.
PMID: 38520475
PMC: 11374507.
DOI: 10.1007/s10585-023-10248-0.
Adam-Artigues A, Salazar L, Aguirre-Ghiso J
Cancer Cell. 2024; 42(1):13-15.
PMID: 38194913
PMC: 11034720.
DOI: 10.1016/j.ccell.2023.12.017.
Dormancy in Breast Cancer.
Dalla E, Sreekumar A, Aguirre-Ghiso J, Chodosh L
Cold Spring Harb Perspect Med. 2023; 13(11.
PMID: 37037598
PMC: 10562521.
DOI: 10.1101/cshperspect.a041331.
Locally sourced: site-specific immune barriers to metastasis.
Correia A
Nat Rev Immunol. 2023; 23(8):522-538.
PMID: 36750616
PMC: 9904275.
DOI: 10.1038/s41577-023-00836-2.
Role of myeloid-derived suppressor cells in tumor recurrence.
Cole K, Al-Kadhimi Z, Talmadge J
Cancer Metastasis Rev. 2023; 42(1):113-142.
PMID: 36640224
PMC: 9840433.
DOI: 10.1007/s10555-023-10079-1.
The genomic regulation of metastatic dormancy.
Gelman I
Cancer Metastasis Rev. 2023; 42(1):255-276.
PMID: 36600151
PMC: 10231431.
DOI: 10.1007/s10555-022-10076-w.
Regulation of Metastatic Tumor Dormancy and Emerging Opportunities for Therapeutic Intervention.
Tamamouna V, Pavlou E, Neophytou C, Papageorgis P, Costeas P
Int J Mol Sci. 2022; 23(22).
PMID: 36430404
PMC: 9698240.
DOI: 10.3390/ijms232213931.
Quantitative cell imaging approaches to metastatic state profiling.
Nevarez A, Hao N
Front Cell Dev Biol. 2022; 10:1048630.
PMID: 36393865
PMC: 9640958.
DOI: 10.3389/fcell.2022.1048630.
Skip to the end: metastasis before tumorigenesis.
Nobre A, Boire A
Nat Genet. 2022; 54(12):1774-1775.
PMID: 36369288
PMC: 11416844.
DOI: 10.1038/s41588-022-01228-3.
ZFP281 drives a mesenchymal-like dormancy program in early disseminated breast cancer cells that prevents metastatic outgrowth in the lung.
Nobre A, Dalla E, Yang J, Huang X, Wullkopf L, Risson E
Nat Cancer. 2022; 3(10):1165-1180.
PMID: 36050483
DOI: 10.1038/s43018-022-00424-8.
Clinical and Biological Aspects of Disseminated Tumor Cells and Dormancy in Breast Cancer.
Ring A, Spataro M, Wicki A, Aceto N
Front Cell Dev Biol. 2022; 10:929893.
PMID: 35837334
PMC: 9274007.
DOI: 10.3389/fcell.2022.929893.
NR2F1 Is a Barrier to Dissemination of Early-Stage Breast Cancer Cells.
Rodriguez-Tirado C, Kale N, Carlini M, Shrivastava N, Rodrigues A, Khalil B
Cancer Res. 2022; 82(12):2313-2326.
PMID: 35471456
PMC: 9203932.
DOI: 10.1158/0008-5472.CAN-21-4145.
The double agents in liquid biopsy: promoter and informant biomarkers of early metastases in breast cancer.
Richard V, Davey M, Annuk H, Miller N, Kerin M
Mol Cancer. 2022; 21(1):95.
PMID: 35379239
PMC: 8978379.
DOI: 10.1186/s12943-022-01506-y.
Circulating Tumor Cells in Breast Cancer Patients: A Balancing Act between Stemness, EMT Features and DNA Damage Responses.
Heitmeir B, Deniz M, Janni W, Rack B, Schochter F, Wiesmuller L
Cancers (Basel). 2022; 14(4).
PMID: 35205744
PMC: 8869884.
DOI: 10.3390/cancers14040997.
KRas-transformed epithelia cells invade and partially dedifferentiate by basal cell extrusion.
Fadul J, Zulueta-Coarasa T, Slattum G, Redd N, Jin M, Redd M
Nat Commun. 2021; 12(1):7180.
PMID: 34893591
PMC: 8664939.
DOI: 10.1038/s41467-021-27513-z.
Systematic extended posterior right sectionectomy with simultaneous resection of the dorsal part of segment 1 and middle hepatic vein detachment.
Burlaka A, Gogo-Abite A, Paliichuk A, Makhmudov D, Zvirych V, Lukashenko A
Clin Case Rep. 2021; 9(9):e04803.
PMID: 34532049
PMC: 8435224.
DOI: 10.1002/ccr3.4803.
Myeloid derived suppressor cells and the release of micro-metastases from dormancy.
Khadge S, Cole K, Talmadge J
Clin Exp Metastasis. 2021; 38(3):279-293.
PMID: 34014424
PMC: 8319840.
DOI: 10.1007/s10585-021-10098-8.